Clinical Trial Update: Hepatic Impairment Study [Phase 1]

View source ↗

Summary

Phase 1 hepatic impairment study sponsored by Bayer has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Disease

Snippet

Sponsor: Bayer | Conditions: Liver Disease | Phase 1 | Status: COMPLETED